Dana Farber Cancer Institute /ID# 152735

450 Brookline Avenue
Boston, Massachusetts 02211

We've found

1 trials

at this facility

A Study Evaluating Venetoclax in Combination With Azacitidine in Subjects With Treatment-Naïve Higher-Risk Myelodysplastic Syndromes (MDS)

Status: Enrolling, Phase I
Updated: 12/31/1969

from

Boston, MA

Use our guide to learn which trials are right for you!